About Targeting DLBCL
At Sobi, we are committed to better understanding the needs of patients at later-line, relapsed/refractory Diffuse Large B-Cell Lymphoma (DLBCL).
As part of this commitment, we have developed the TARGETING DLBCL initiative to better understand the perspectives of HaemOncs who are managing later-line DLBCL.
Give your perspective
The core element of the TARGETING DLBCL initiative is the DLBCL POLL – a global, interactive poll
- Access latest information about later-line DLBCL management
- Give your perspectives on later-line DLBCL
- See your peers’ views
Complete the polls now
Typical patient with later-line DLBCL
Click here to see this short film that shows a typical patient with later-line DLBCL. The film conveys the emotions these patients and their families may experience – but also reminds us of that realistic optimism that may be achievable with the right management.
International experts in DLBCL
Access the knowledge of international experts in DLBCL with our selection of videos. Listen to their opinions on a variety of topics, including unmet disease and patient needs, what they think of new treatments and what they believe are the biggest challenges remaining.
Professor Carmelo Carlo-Stella
Dr. Paolo Strati
Professor Carmelo Carlo-Stella
Dr. Paolo Strati
Dr. Paolo Strati
Dr. Paolo Strati